Alnylam Pharmaceuticals Statistics
Total Valuation
ALNY has a market cap or net worth of $38.90 billion. The enterprise value is $38.86 billion.
| Market Cap | 38.90B |
| Enterprise Value | 38.86B |
Important Dates
The next estimated earnings date is Thursday, July 30, 2026, before market open.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALNY has 133.51 million shares outstanding. The number of shares has increased by 6.45% in one year.
| Current Share Class | 133.51M |
| Shares Outstanding | 133.51M |
| Shares Change (YoY) | +6.45% |
| Shares Change (QoQ) | +1.43% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 99.34% |
| Float | 132.94M |
Valuation Ratios
The trailing PE ratio is 73.76 and the forward PE ratio is 34.80.
| PE Ratio | 73.76 |
| Forward PE | 34.80 |
| PS Ratio | 9.07 |
| Forward PS | 6.36 |
| PB Ratio | 36.16 |
| P/TBV Ratio | 36.17 |
| P/FCF Ratio | 60.47 |
| P/OCF Ratio | 54.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 48.16, with an EV/FCF ratio of 60.41.
| EV / Earnings | 72.24 |
| EV / Sales | 9.07 |
| EV / EBITDA | 48.16 |
| EV / EBIT | 51.67 |
| EV / FCF | 60.41 |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 2.76.
| Current Ratio | 3.13 |
| Quick Ratio | 2.88 |
| Debt / Equity | 2.76 |
| Debt / EBITDA | 3.36 |
| Debt / FCF | 4.62 |
| Interest Coverage | 2.85 |
Financial Efficiency
Return on equity (ROE) is 90.36% and return on invested capital (ROIC) is 78.43%.
| Return on Equity (ROE) | 90.36% |
| Return on Assets (ROA) | 10.06% |
| Return on Invested Capital (ROIC) | 78.43% |
| Return on Capital Employed (ROCE) | 19.90% |
| Weighted Average Cost of Capital (WACC) | 5.93% |
| Revenue Per Employee | $1.71M |
| Profits Per Employee | $215,196 |
| Employee Count | 2,500 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 10.99 |
Taxes
In the past 12 months, ALNY has paid $9.18 million in taxes.
| Income Tax | 9.18M |
| Effective Tax Rate | 1.68% |
Stock Price Statistics
The stock price has decreased by -9.50% in the last 52 weeks. The beta is 0.27, so ALNY's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -9.50% |
| 50-Day Moving Average | 296.63 |
| 200-Day Moving Average | 370.21 |
| Relative Strength Index (RSI) | 49.20 |
| Average Volume (20 Days) | 1,301,317 |
Short Selling Information
The latest short interest is 5.44 million, so 4.07% of the outstanding shares have been sold short.
| Short Interest | 5.44M |
| Short Previous Month | 5.30M |
| Short % of Shares Out | 4.07% |
| Short % of Float | 4.09% |
| Short Ratio (days to cover) | 5.14 |
Income Statement
In the last 12 months, ALNY had revenue of $4.29 billion and earned $537.99 million in profits. Earnings per share was $3.95.
| Revenue | 4.29B |
| Gross Profit | 3.46B |
| Operating Income | 752.14M |
| Pretax Income | 547.17M |
| Net Income | 537.99M |
| EBITDA | 806.94M |
| EBIT | 752.14M |
| Earnings Per Share (EPS) | $3.95 |
Balance Sheet
The company has $3.01 billion in cash and $2.97 billion in debt, giving a net cash position of $38.99 million or $0.29 per share.
| Cash & Cash Equivalents | 3.01B |
| Total Debt | 2.97B |
| Net Cash | 38.99M |
| Net Cash Per Share | $0.29 |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 8.06 |
| Working Capital | 2.87B |
Cash Flow
In the last 12 months, operating cash flow was $714.90 million and capital expenditures -$71.56 million, giving a free cash flow of $643.34 million.
| Operating Cash Flow | 714.90M |
| Capital Expenditures | -71.56M |
| Depreciation & Amortization | 54.81M |
| Net Borrowing | -546.95M |
| Free Cash Flow | 643.34M |
| FCF Per Share | $4.82 |
Margins
Gross margin is 80.83%, with operating and profit margins of 17.54% and 12.55%.
| Gross Margin | 80.83% |
| Operating Margin | 17.54% |
| Pretax Margin | 12.76% |
| Profit Margin | 12.55% |
| EBITDA Margin | 18.82% |
| EBIT Margin | 17.54% |
| FCF Margin | 15.01% |
Dividends & Yields
ALNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.45% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.38% |
| FCF Yield | 1.65% |
Analyst Forecast
The average price target for ALNY is $436.32, which is 49.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $436.32 |
| Price Target Difference | 49.75% |
| Analyst Consensus | Buy |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 32.91% |
| EPS Growth Forecast (3Y) | 48.23% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALNY has an Altman Z-Score of 7.37 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.37 |
| Piotroski F-Score | 6 |